1. Home
  2. CRGX vs VLGEA Comparison

CRGX vs VLGEA Comparison

Compare CRGX & VLGEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • VLGEA
  • Stock Information
  • Founded
  • CRGX 2021
  • VLGEA 1937
  • Country
  • CRGX United States
  • VLGEA United States
  • Employees
  • CRGX N/A
  • VLGEA N/A
  • Industry
  • CRGX
  • VLGEA Food Chains
  • Sector
  • CRGX
  • VLGEA Consumer Staples
  • Exchange
  • CRGX Nasdaq
  • VLGEA Nasdaq
  • Market Cap
  • CRGX 190.0M
  • VLGEA 541.1M
  • IPO Year
  • CRGX 2023
  • VLGEA N/A
  • Fundamental
  • Price
  • CRGX $4.46
  • VLGEA $39.09
  • Analyst Decision
  • CRGX Hold
  • VLGEA
  • Analyst Count
  • CRGX 7
  • VLGEA 0
  • Target Price
  • CRGX $4.67
  • VLGEA N/A
  • AVG Volume (30 Days)
  • CRGX 502.9K
  • VLGEA 88.0K
  • Earning Date
  • CRGX 08-11-2025
  • VLGEA 06-03-2025
  • Dividend Yield
  • CRGX N/A
  • VLGEA 2.56%
  • EPS Growth
  • CRGX N/A
  • VLGEA 12.55
  • EPS
  • CRGX N/A
  • VLGEA 3.80
  • Revenue
  • CRGX N/A
  • VLGEA $2,299,253,000.00
  • Revenue This Year
  • CRGX $57.81
  • VLGEA N/A
  • Revenue Next Year
  • CRGX N/A
  • VLGEA N/A
  • P/E Ratio
  • CRGX N/A
  • VLGEA $10.29
  • Revenue Growth
  • CRGX N/A
  • VLGEA 3.94
  • 52 Week Low
  • CRGX $3.00
  • VLGEA $24.90
  • 52 Week High
  • CRGX $25.45
  • VLGEA $40.15
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 57.89
  • VLGEA 61.02
  • Support Level
  • CRGX $4.09
  • VLGEA $38.03
  • Resistance Level
  • CRGX $4.51
  • VLGEA $39.65
  • Average True Range (ATR)
  • CRGX 0.18
  • VLGEA 0.90
  • MACD
  • CRGX 0.00
  • VLGEA 0.08
  • Stochastic Oscillator
  • CRGX 77.18
  • VLGEA 81.52

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.

About VLGEA Village Super Market Inc.

Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.

Share on Social Networks: